Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression
| Class:Id | LiteratureReference:9761593 |
| _displayName | NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression |
| _timestamp | 2022-01-15 22:46:00 |
| author | [Person:3215299] Chen, Delin [Person:9761591] Tavana, Omid [Person:9761590] Chu, Bo [Person:9761592] Erber, Luke [Person:2187366] Chen, Y [Person:9706971] Baer, Richard [Person:3215293] Gu, Wei |
| created | [InstanceEdit:9761594] Rothfels, Karen, 2022-01-15 |
| journal | Mol Cell |
| pages | 224-232.e4 |
| pubMedIdentifier | 28985506 |
| title | NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression |
| volume | 68 |
| year | 2017 |
| (literatureReference) | [Complex:9761741] SLC7A11 gene:p-AcK-NFE2L2:ATF4 [nucleoplasm] [Homo sapiens] [RegulationReference:9761803] Negative regulation by 'p-NFE2L2:CREBBP,EP300;p14ARF [nucleoplasm]' NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression [RegulationReference:9761856] Positive gene expression regulation by 'SLC7A11 gene:p-AcK-NFE2L2:ATF4 [nucleoplasm]' NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression [Reaction:9761815] AcK-NFE2L2 and ATF4 bind the SLC7A11 gene [Homo sapiens] [Reaction:9761836] p14ARF binds NFE2L2:CREBBP, EP300 [Homo sapiens] [BlackBoxEvent:9761841] AcK-NFE2L2-dependent SLC7A11 expression [Homo sapiens] |
|
[Change default viewing format]
|
No pathways have been reviewed or authored by NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression (9761593)